Provided by Tiger Fintech (Singapore) Pte. Ltd.

Regulus Therapeutics

3.37
-0.1200-3.44%
Post-market: 3.36-0.0100-0.30%19:54 EDT
Volume:2.20M
Turnover:7.41M
Market Cap:223.24M
PE:-4.10
High:3.60
Open:3.50
Low:3.21
Close:3.49
Loading ...
May 13, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 12, 2022

Major Issues Report

8-K - Current report
Mar 11, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 10, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 02, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 12, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jan 05, 2022

Major Issues Report

8-K - Current report
Jan 04, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 09, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Dec 08, 2021

Correspondence

CORRESP [Cover] - Correspondence
Dec 02, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Nov 30, 2021

Major Issues Report

8-K - Current report
Nov 29, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Nov 24, 2021

Major Issues Report

8-K - Current report
Nov 12, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 10, 2021

Major Issues Report

8-K - Current report